GlassScriptPhysician profile
James D West
NPI 1689614174
$888.89
in general payments reported to CMS, 2019-2025
11 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $44.34 · 2021: $276 · 2023: $80.45 · 2024: $89.93 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $235.22 | 2019-2021 | |
| Exact Sciences Corporation | $140.55 | 2025 | The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals LP | $124.99 | 2021 | |
| Roche Diagnostics Corporation | $124.73 | 2019-2021 | |
| Hologic Sales and Service, LLC | $110.28 | 2021-2025 | Aptima, Novasure, Fluent Fluid Management System |
| Gilead Sciences, INC. | $64.46 | 2023 | Epclusa |
| Bayer Healthcare Pharmaceuticals INC. | $19.95 | 2024 | |
| Lilly USA, LLC | $19.81 | 2024 | Zepbound |
| Medline Industries LP | $16.56 | 2024 | Medline Industries, INC. |
| Myovant Sciences INC. | $16.35 | 2021 | |
| Shield Therapeutics INC | $15.99 | 2023 | Accrufer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.